World's Best Scientists 2026 revealed!
Paola Guglielmelli

Paola Guglielmelli

D-Index & Metrics

Medicine

D-Index
81
Citations
27990
World Ranking
16502
National Ranking
655

Paola Guglielmelli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paola Guglielmelli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 493 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paola Guglielmelli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paola Guglielmelli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paola Guglielmelli is affiliated with the University of Florence in Italy and specializes in medicine, with a significant focus on genetics, hematology, and molecular biology. Their research encompasses a wide range of subfields including rheumatology and immunology.

Their work primarily addresses topics related to myeloproliferative neoplasms (MPNs), with an emphasis on diagnosis and treatment strategies. Additional topics covered in their research include acute myeloid leukemia, eosinophilic disorders and syndromes, chronic myeloid leukemia treatments, Kruppel-like factors, hemoglobinopathies, and multiple myeloma research.

Frequent venues for publication include Blood, American Journal of Hematology, Blood Cancer Journal, Leukemia, and HemaSphere.

They have collaborated extensively with other researchers, notably:

  • Alessandro M. Vannucchi
  • Giuseppe Gaetano Loscocco
  • Francesco Mannelli
  • Tiziano Barbui
  • Valerio De Stefano

Some of their recent papers highlight contributions to the understanding of polycythemia vera and essential thrombocythaemia, including:

  • JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis, 2021, Blood Cancer Journal
  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera, 2020, British Journal of Haematology
  • Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial, 2021, The Lancet Haematology
  • High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib, 2021, Leukemia
  • Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera, 2022, Blood Cancer Journal

Best Publications

  • Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

    J. Nangalia;C.E. Massie;E.J. Baxter;F.L. Nice

  • Mutations and prognosis in primary myelofibrosis

    Alessandro Maria Vannucchi;Tl Lasho;Paola Guglielmelli;Flavia Biamonte

  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Francesco Passamonti;Francisco Cervantes;Alessandro Maria Vannucchi;Enrica Morra

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Effect of Mutation Order on Myeloproliferative Neoplasms

    Christina A. Ortmann;David G. Kent;Jyoti Nangalia;Yvonne Silber

  • The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

    Tiziano Barbui;Jürgen Thiele;Heinz Gisslinger;Hans Michael Kvasnicka

  • Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

    Jacob Grinfeld;Jyoti Nangalia;E Joanna Baxter;David C Wedge

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

    Giada Rotunno;Carmela Mannarelli;Paola Guglielmelli;Annalisa Pacilli

  • Prospective identification of high-risk polycythemia vera patients based on JAK2 V617F allele burden

    Alessandro Maria Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;G. Longo

  • Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

    Elisa Rumi;Daniela Pietra;Cristiana Pascutto;Paola Guglielmelli

  • Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

    Valerio De Stefano;Tommaso Za;Elena Rossi;Alessandro M. Vannucchi

  • IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

    A Tefferi;T L Lasho;O Abdel-Wahab;P Guglielmelli

  • Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.

    A M Vannucchi;E Antonioli;P Guglielmelli;A Pardanani

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • Advances in understanding and management of myeloproliferative neoplasms.

    Alessandro M. Vannucchi;Paola Guglielmelli;Ayalew Tefferi

  • MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Terra L. Lasho;Naseema Gangat

  • Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    Ayalew Tefferi;Terra L. Lasho;Paola Guglielmelli;Christy M. Finke

  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

    A Tefferi;P Guglielmelli;T L Lasho;G Rotunno

Frequent Co-Authors

Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Alberto Bosi
Alberto Bosi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Mario Cazzola
Mario Cazzola University of Pavia
Giovanni Barosi
Giovanni Barosi University of Pavia
Francesco Passamonti
Francesco Passamonti University of Milan
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Daniela Pietra
Daniela Pietra University of Pavia
Guido Finazzi
Guido Finazzi Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Medicine opens doors to a wide array of related careers within the healthcare industry. Many students and professionals are turning to online programs for flexibility and affordability. For those aiming to advance their clinical expertise, the cheapest dnp program options offer pathways for nurses seeking a Doctor of Nursing Practice degree without a hefty financial burden.

Pharmacy professionals can also benefit from accredited pharm d online programs, which are designed for those who aspire to become licensed pharmacists while balancing work and study.

If you are interested in the management side of healthcare, earning an accredited qualification through rhit programs online can help you establish a career in health information management. Alternatively, those looking for entry points into the medical field should explore billing and coding classes online, which prepare you for administrative roles in health organizations.

Each of these online pathways provides unique opportunities to diversify your skills and meet the evolving demands of the healthcare sector in the USA.

Best Scientists Citing Paola Guglielmelli

Trending Scientists

Recently Published Articles